bluebird bio



bluebird bio is developing innovative gene therapies for severe genetic diseases and cancer. Its vision is to make the hope of gene therapy a reality.

Andrew Obenshain
President, Severe Genetic Diseases
Jason F. Cole
Chief Operating & Legal Officer
Chip Baird
Philip D. Gregory
Chief Scientific Officer
Kathy Wilkinson
Chief People Officer
Nicola Heffron
COO, Oncology
Doug Danison
Head of Europe
Alison Conlon
VP, Portfolio & Program Management
Tom Klima
Chief Commercial Officer
Richard Colvin
Chief Medical Officer
Anne-Virginie Eggimann
Chief Regulatory Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.